Genitourinary cancer treatment in Gainesville, Florida

Brian Ramnaraign, MD is a cancer specialist (oncologist) and hematology and oncology specialist located at 1535 Gale Lemerand Drive, Gainesville, Florida, United States. Dr. Ramnaraign is an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine. His expertise lies in genitourinary cancers, gastrointestinal cancers, and neuroendocrine cancers, with a focus on personalized treatments using targeted therapies and immunotherapies. Dr. Ramnaraign completed his medical training at the University of Toronto and St. George’s University, followed by residency at SUNY Downstate and a fellowship at the University of Florida. Patients appreciate his compassionate care and dedication to providing the best treatment options for their individual needs.

Brian Ramnaraign, MD is a renowned Cancer Specialist (Oncologist) and Hematology and Oncology Specialist located at 1600 Southwest Archer Road in Gainesville, Florida, United States. As an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine, Dr. Ramnaraign brings a wealth of knowledge and expertise to his practice. Dr. Ramnaraign's educational background includes an Honors Bachelors of Science degree with a specialization in molecular genetics and microbiology from the University of Toronto, as well as a Doctor of Medicine degree from St. George’s University, where he graduated cum laude. He completed his internal medicine residency at SUNY Downstate in Brooklyn, NY, and a fellowship in geriatrics at the University of Pennsylvania in Philadelphia, PA.

Jonathan Chatzkel, MD is a renowned cancer specialist (oncologist) and hematology and oncology specialist located at 1535 Gale Lemerand Drive in Gainesville, Florida, United States. Dr. Chatzkel is an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine. He graduated magna cum laude from the University of Pennsylvania with a Bachelor of Arts degree in Economics before completing his medical degree at the Perelman School of Medicine. Dr. Chatzkel has a strong clinical interest in genitourinary cancers, including kidney, bladder, prostate, and testis cancers, and is dedicated to providing individualized care to each patient. He is affiliated with the American Society of Clinical Oncology (ASCO) and is involved in various clinical trials, such as a Phase 1b study evaluating the safety and efficacy of XL092 alone and in combination with nivolumab. Additionally, Dr. Chatzkel is leading Phase III trials comparing different treatment options for high-risk prostate cancer and renal cell carcinoma.